ZURZUVAE is a 14-day treatment
that may offer relief starting in 3 days
Rapid relief
starting at Day 3
See the results
starting at Day 3
In a clinical study, ZURZUVAE
improved PPD symptoms at
Day 15 and as fast as Day 3.
ZURZUVAE is taken
for 14 days
Get the details
for 14 days
Here’s what to keep in mind
about treatment.
Watch patient stories
Hear from others
Hear from women about their
experience with PPD and
ZURZUVAE.
*These are not all the symptoms of PPD. Only a healthcare provider can diagnose PPD.
ZURZUVAE 50 mg was studied in women with PPD whose symptoms started in the third trimester or within 4 weeks of delivery in a 6-week trial. During the trial, patients took either ZURZUVAE or placebo for 14 days, and were followed up for another 4 weeks. Significantly greater PPD symptom improvement was demonstrated at Day 3, Day 15 (the primary endpoint), and Day 45 compared to placebo, using a standard depression rating scale.
ZURZUVAE For You is a patient support program that is here to help as you navigate your ZURZUVAE treatment journey.
Connect through telehealth
Take a short assessment about your
needs and medical history.
Get matched with healthcare
providers
who may be a fit for you.
Schedule a visit to talk about your
symptoms.
Supernus Pharmaceuticals and Biogen are providing this link to an independent third party as a resource for your use. This link is not a
recommendation. Supernus Pharmaceuticals and Biogen are not responsible for nor do they control the content of any linked websites.